Viewing Study NCT00376961


Ignite Creation Date: 2025-12-24 @ 12:56 PM
Ignite Modification Date: 2025-12-30 @ 8:11 AM
Study NCT ID: NCT00376961
Status: COMPLETED
Last Update Posted: 2017-11-06
First Post: 2006-09-13
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
Sponsor: SWOG Cancer Research Network
Organization: